Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Deferred Tax Assets Current Leases Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

ASP Isotopes (ASPI) Inventory (2024 - 2025)

ASP Isotopes has reported Inventory over the past 2 years, most recently at $1.1 million for Q4 2025.

For Q4 2025, Inventory rose 1563.64% year-over-year to $1.1 million; the TTM value through Dec 2025 reached $1.1 million, up 1563.64%, while the annual FY2025 figure was $1.1 million, 1563.64% up from the prior year.
Inventory for Q4 2025 was $1.1 million at ASP Isotopes, down from $1.4 million in the prior quarter.
Over five years, Inventory peaked at $1.4 million in Q3 2025 and troughed at $66000.0 in Q4 2024.